Researchers have discovered unique populations of neurons in the spinal cords of patients who died of amyotrophic lateral sclerosis that could be utilized as potential drug targets.
A novel artificial intelligence and biosensor device has been developed to monitor if live caner cells remain after chemotherapy treatment.
Take a look at our overview of the top events in the world of bioanalysis for July, August and September 2019.
Frontage Holdings Corporation announces successful initial public offering on the Hong Kong stock exchange
Frontage Holdings Corporation has recently announced that they have begun trading on the main board of the stock exchange of Hong Kong.
Verify Life Science LLC (CA, USA), health and life sciences company under Alphabet, recently announced its partnerships with four major pharmaceutical companies to allow them to move into the clinical trial market.
An isobaric labeling technique has been developed to amplify signals for comprehensive quantitative phosphoproteomic characterization of small cells populations.
Global leaders in life sciences and nonclinical drug development, Envigo (Huntingdon, UK) and LabCorp (NC, USA), have signed an innovative agreement in a bid to expand nonclinical drug development capabilities and create an independent research models provider.
Researchers have developed a novel technology to test for viral infections by detecting small amounts of antibodies in the blood.
A prototype wearable device has been developed to continuously collect live cancer cells directly from a patient’s blood, presenting an alternative to biopsies.
Take a look at our overview of the top events in the world of bioanalysis for April, May and June 2019.